VIMC [Vimicro International] 6-K: (Original Filing)

[Vimicro Announces Unaudited Third-Quarter 2013 Financial Results BEIJING, China — November 4 , 2013 — Vimicro International Corporation (NASDAQ: VIMC) (“Vimicro” or the “Company”), a leading video processing IC and surveillance solution provider, today announced unaudited financial results for the third quarter ended September 30, 2013 . Third-Quarter 2013 Results Net revenue in the third quarter of 2013 was $] [VIMICRO INTERNATIONAL CORPORATION 15/F Shining Tower Form 20-F x Form 40-F o o o VIMICRO INTERNATIONAL CORPORATION John Zhonghan Deng]

By | 2016-03-31T17:58:34+00:00 November 5th, 2013|Categories: Chinese Stocks, SEC Original, VIMC|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 10-Q: (Original Filing)

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [David (Xiaoying) Gao , the Chief Executive Officer of CHINA BIOLOGIC PRODUCTS, INC. (the “Company”), DOES HEREBY CERTIFY that: 1. September 30 , 201 3 2. 5 th day of November , 201 3 . David (Xiaoying) Gao Chief Executive Officer A signed original of this written statement required by Section 906 has been provided to China Biologic Products, Inc.] [Ming Yang , the Chief Financial Officer of CHINA BIOLOGIC PRODUCTS, INC. (the “Company”), DOES HEREBY CERTIFY that: 1. 3 2. 5 th day of November , 201 3 . Ming Yang Ming Yang Chief Financial Officer (Principal Financial Officer) A signed original of this written statement required by Section 906 has been provided to China Biologic Products, Inc. and]

SSW [Seaspan] FWP: (Original Filing)

[Registration No. 333-190718 SUMMARY OF FINAL TERMS November 5, 2013 $50,000,000 SEASPAN CORPORATION 7.95% SERIES D CUMULATIVE REDEEMABLE PERPETUAL PREFERRED SHARES This summary pricing sheet relates only to the securities described below and should only be read together with the Preliminary Prospectus Supplement, subject to completion, dated November 5, 2013, relating to these securities and supersedes the information in the]

By | 2016-03-10T13:05:37+00:00 November 5th, 2013|Categories: Chinese Stocks, SEC Original, SSW|Tags: , , , , , |0 Comments

EGT [Entertainment Gaming Asia] 8-K: (Original Filing)

[CONTACTS: Entertainment Gaming Asia Inc. Traci Mangini tracimangini@EGT-Group.com 312/867-0848 RESULTS ENTERTAINMENT GAMING ASIA INC. REPORTS THIRD QUARTER 2013 AND PROVIDES MARKET UPDATE Hong Kong – November 5, 2013 – Entertainment Gaming Asia Inc. (NASDAQ: EGT) (“Entertainment Gaming Asia” or “the Company”), a leading gaming company focused on emerging gaming markets in Pan-Asia, today reported operating results for the third quarter] [ENTERTAINMENT GAMING ASIA INC. Nevada 001-32161 91-1696010 (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification Number) Unit C1, Ground Floor, Koon Wah Building No. 2 Yuen Shun Circuit Yuen Chau Kok, Shatin New Territories, Hong Kong SAR + 852-3147-6600 Not applicable (Former name or former address, if changed since last report) o o o o Item 2.02 Results of]

By | 2016-03-13T23:05:35+00:00 November 5th, 2013|Categories: Chinese Stocks, EGT, SEC Original|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China – November 4, 2013 – Mindray Medical International Limited (“Mindray” or “Company”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today and]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China – November 4, 2013 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2013. Highlights for Third Quarter 2013 • Net revenues increased 15.3% year-over-year to $296.3 million. International]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November4, 2013 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China November4, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2013. Highlights for Third Quarter 2013 Net revenuesreased 15.3% year-over-year to $296.3 million. Internationalles grew]

Skip to toolbar